chrX-141241617-T-C
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_022661.4(SPANXC):c.194A>G(p.Glu65Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_022661.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022661.4. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.00238 AC: 148AN: 62099Hom.: 5 Cov.: 9 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 22AN: 177640 AF XY: 0.0000477 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000242 AC: 259AN: 1070805Hom.: 1 Cov.: 35 AF XY: 0.000122 AC XY: 42AN XY: 343339 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00238 AC: 148AN: 62112Hom.: 5 Cov.: 9 AF XY: 0.00218 AC XY: 25AN XY: 11486 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at